Cardiac and CNS Toxicity of Levobupivacaine: Strengths of Evidence for Advantage Over Bupivacaine

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.3, 2002-01, pp. : 153-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The local anaesthetic activity of levobupivacaine does not differ from racemic bupivacaine (marcain): first clinical evidence

By Bardsley H. Gristwood R. Watson N. Nimmo W.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1883-1886

Informa Healthcare

Access to resources Recommend Favorite

Bupivacaine: CNS toxicity following inadvertent IV administration treated with soya oil emulsion: case report

Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Bupivacaine/fentanyl/levobupivacaine: Harlequin appearance in a child: case report

Reactions Weekly, Vol. 1, Iss. 1356, 2011-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Levobupivacaine

By McClellan K.J. Spencer C.M.

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 355-362

Adis International

Access to resources Recommend Favorite

Mepivacaine/prilocaine: CNS and cardiac toxicity in an elderly patient, treated with soya oil emulsion: case report

Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite